A detailed history of United Capital Financial Advisers, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, United Capital Financial Advisers, LLC holds 20,628 shares of ZTS stock, worth $3.62 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
20,628
Previous 20,279 1.72%
Holding current value
$3.62 Million
Previous $3.52 Million 14.65%
% of portfolio
0.02%
Previous 0.03%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$172.58 - $196.48 $60,230 - $68,571
349 Added 1.72%
20,628 $4.03 Million
Q2 2024

Aug 14, 2024

SELL
$145.54 - $178.83 $426,868 - $524,508
-2,933 Reduced 12.64%
20,279 $3.52 Million
Q1 2024

May 15, 2024

SELL
$165.67 - $199.94 $683,554 - $824,952
-4,126 Reduced 15.09%
23,212 $3.93 Million
Q4 2023

Feb 14, 2024

SELL
$151.44 - $200.09 $3.27 Million - $4.32 Million
-21,589 Reduced 44.12%
27,338 $5.4 Million
Q3 2023

Nov 14, 2023

SELL
$167.14 - $192.77 $109,142 - $125,878
-653 Reduced 1.32%
48,927 $8.51 Million
Q2 2023

Aug 14, 2023

SELL
$160.94 - $186.23 $413,132 - $478,052
-2,567 Reduced 4.92%
49,580 $8.54 Million
Q1 2023

Aug 14, 2023

BUY
$145.48 - $175.02 $373,447 - $449,276
2,567 Added 5.18%
52,147 $8.68 Million
Q1 2023

May 15, 2023

SELL
$145.48 - $175.02 $461,171 - $554,813
-3,170 Reduced 5.73%
52,147 $8.68 Million
Q4 2022

Feb 14, 2023

SELL
$131.14 - $157.47 $2.13 Million - $2.56 Million
-16,232 Reduced 22.69%
55,317 $8.11 Million
Q3 2022

Nov 14, 2022

SELL
$148.29 - $182.55 $519,311 - $639,290
-3,502 Reduced 4.67%
71,549 $10.6 Million
Q2 2022

Aug 11, 2022

BUY
$155.97 - $200.09 $344,225 - $441,598
2,207 Added 3.03%
75,051 $12.9 Million
Q1 2022

May 16, 2022

BUY
$181.39 - $234.03 $612,735 - $790,553
3,378 Added 4.86%
72,844 $13.7 Million
Q4 2021

Feb 14, 2022

BUY
$193.69 - $247.03 $50,940 - $64,968
263 Added 0.38%
69,466 $17 Million
Q3 2021

Nov 15, 2021

BUY
$189.29 - $209.69 $2.1 Million - $2.33 Million
11,112 Added 19.13%
69,203 $13.4 Million
Q2 2021

Aug 13, 2021

BUY
$155.9 - $187.99 $7.58 Million - $9.13 Million
48,593 Added 511.61%
58,091 $10.8 Million
Q1 2021

May 14, 2021

BUY
$144.0 - $169.39 $83,088 - $97,738
577 Added 6.47%
9,498 $1.5 Million
Q4 2020

Feb 17, 2021

BUY
$157.07 - $174.35 $107,435 - $119,255
684 Added 8.3%
8,921 $1.48 Million
Q3 2020

Nov 13, 2020

BUY
$137.1 - $165.37 $43,049 - $51,926
314 Added 3.96%
8,237 $1.36 Million
Q2 2020

Aug 13, 2020

BUY
$111.92 - $142.53 $28,203 - $35,917
252 Added 3.29%
7,923 $1.09 Million
Q1 2020

May 15, 2020

SELL
$92.66 - $144.94 $349,050 - $545,988
-3,767 Reduced 32.93%
7,671 $903,000
Q4 2019

Feb 14, 2020

BUY
$116.25 - $133.25 $384,090 - $440,258
3,304 Added 40.62%
11,438 $1.51 Million
Q3 2019

Feb 14, 2020

BUY
$112.57 - $128.43 $915,644 - $1.04 Million
8,134 New
8,134 $1.01 Million
Q3 2019

Nov 14, 2019

SELL
$112.57 - $128.43 $2.6 Million - $2.97 Million
-23,127 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$97.98 - $114.28 $823,129 - $960,066
8,401 Added 57.05%
23,127 $2.61 Million
Q1 2019

May 14, 2019

SELL
$81.56 - $100.67 $765,766 - $945,190
-9,389 Reduced 38.93%
14,726 $1.48 Million
Q4 2018

Feb 14, 2019

BUY
$79.28 - $95.27 $467,434 - $561,711
5,896 Added 32.36%
24,115 $2.04 Million
Q3 2018

Nov 14, 2018

SELL
$83.5 - $93.23 $29,893 - $33,376
-358 Reduced 1.93%
18,219 $1.67 Million
Q2 2018

Aug 14, 2018

BUY
$79.9 - $89.2 $9,987 - $11,150
125 Added 0.68%
18,577 $1.58 Million
Q1 2018

May 15, 2018

BUY
$71.51 - $84.69 $479,832 - $568,269
6,710 Added 57.15%
18,452 $1.54 Million
Q4 2017

Feb 13, 2018

BUY
$63.24 - $72.8 $55,398 - $63,772
876 Added 8.06%
11,742 $846,000
Q3 2017

Nov 14, 2017

SELL
$59.73 - $65.4 $10,154 - $11,118
-170 Reduced 1.54%
10,866 $693,000
Q2 2017

Aug 14, 2017

BUY
N/A
11,036
11,036 $688,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.3B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track United Capital Financial Advisers, LLC Portfolio

Follow United Capital Financial Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on United Capital Financial Advisers, LLC with notifications on news.